Bayesian Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,100	Closed	-$394K	–	445
2025 Q3	$394K	Buy	+13,100	New	+$393K	0.08%	333
2025 Q2	–	Sell	-13,783	Closed	-$499K	–	813
2025 Q1	$499K	Buy	13,783 +5,515	+67%	+$229K	0.08%	294
2024 Q4	$348K	Sell	8,268 -5,568	-40%	-$276K	0.04%	457
2024 Q3	$769K	Buy	+13,836	New	+$705K	0.09%	284
2024 Q2	–	Sell	-15,302	Closed	-$714K	–	1029
2024 Q1	$714K	Buy	+15,302	New	+$722K	0.07%	368
2023 Q2	–	Sell	-16,263	Closed	-$652K	–	1010
2023 Q1	$652K	Buy	+16,263	New	+$698K	0.08%	324
2022 Q2	–	Sell	-9,200	Closed	-$668K	–	1030
2022 Q1	$668K	Buy	+9,200	New	+$640K	0.1%	297
2019 Q2	–	Sell	-3,753	Closed	-$260K	–	657
2019 Q1	$260K	Buy	+3,753	New	+$214K	0.05%	420